Objective:

To provide insights into the role of the immune system in autoimmune skin disorders and discuss emerging immunotherapies as treatment strategies.

Approach:

• Keratinocyte Function: Keratinocytes are active participants in immune responses, involved in cytokine production and immune cell recruitment.
• Pemphigus Vulgaris Insights: Research highlights the role of NK cells and macrophages in the pathogenesis of pemphigus vulgaris.
• Advancements in Vitiligo Treatment: Next-generation targeted immunotherapies, including JAK inhibitors, are being developed for vitiligo.
• Multi-Omics in Systemic Sclerosis: Multi-omics techniques are revealing cell-specific therapeutic targets in systemic sclerosis.
• Neutrophil Role in Psoriasis: Neutrophil extracellular traps (NETs) are implicated in psoriasis, with potential therapeutic targets identified.
• IL-23 Targeting in Psoriasis: Selective targeting of the IL-23 p19 subunit has shown significant improvements in psoriasis treatment outcomes.

Key Findings:

• Keratinocytes play a crucial role in shaping immune responses in various skin conditions.
• NK cells and macrophages are critical in the pathogenesis of pemphigus vulgaris.
• JAK inhibitors have been FDA approved for vitiligo treatment.
• Multi-omics approaches are shifting treatment strategies towards targeted immunotherapies in systemic sclerosis.
• NETs contribute to disease activity in psoriasis, presenting new therapeutic targets.
• IL-23 p19 blockade has demonstrated significant efficacy in psoriasis treatment.

Interpretation:

The editorial discusses the complexity of immune interactions in skin disorders and the potential of targeted immunotherapies.

Limitations:

• Critical gaps remain in understanding the complex networks involved in autoimmune skin disorders.
• Current immunotherapies have limitations that need to be addressed.

Conclusion:

Emerging therapies targeting immune pathways may offer more effective treatments for autoimmune skin disorders.